|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07H 15/234 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/12 | (2006.01) | ||
| A61K 9/72 | (2006.01) | ||
| A61K 31/7036 | (2006.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 47/02 | (2006.01) |
| (11) | Number of the document | 1273292 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01116071.0 |
| Date of filing the European patent application | 2001-07-02 | |
| (97) | Date of publication of the European application | 2003-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2004-05-26 |
| (46) | Date of publication of the claims translation | 2004-09-27 |
| (72) |
Malvolti, Chiara, IT
Garzia, Raffaella, IT
|
| (73) |
CHIESI FARMACEUTICI S.p.A.,
Via Palermo, 26/A, 43100 Parma PR,
IT
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Optimizuota pavertimui aerozoliu tobramicino kompozicija |
| Optimised formulation of tobramycin for aerosolization |
| Payment date | Validity (years) | Amount | |
| 2020-07-01 | 347.00 EUR |